298 related articles for article (PubMed ID: 17024556)
1. Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features.
Gamblin TC; Edington H; Kirkwood JM; Rao UN
Ann Surg Oncol; 2006 Dec; 13(12):1664-70. PubMed ID: 17024556
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients.
Su LD; Fullen DR; Sondak VK; Johnson TM; Lowe L
Cancer; 2003 Jan; 97(2):499-507. PubMed ID: 12518375
[TBL] [Abstract][Full Text] [Related]
3. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution.
Ludgate MW; Fullen DR; Lee J; Lowe L; Bradford C; Geiger J; Schwartz J; Johnson TM
Cancer; 2009 Feb; 115(3):631-41. PubMed ID: 19123453
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors).
Murali R; Sharma RN; Thompson JF; Stretch JR; Lee CS; McCarthy SW; Scolyer RA
Ann Surg Oncol; 2008 Jan; 15(1):302-9. PubMed ID: 18000712
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents.
Roaten JB; Partrick DA; Pearlman N; Gonzalez RJ; Gonzalez R; McCarter MD
J Pediatr Surg; 2005 Jan; 40(1):232-5. PubMed ID: 15868590
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy in elderly irish patients with malignant melanoma.
Moran DE; Smith MJ; O'Sullivan MJ; Bannon H; Crotty TB; Collins CD; Skehan SJ; O'Higgins N; McDermott EW; Evoy D; Hill AD
Ir Med J; 2007 Apr; 100(4):422-4. PubMed ID: 17566474
[TBL] [Abstract][Full Text] [Related]
8. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
[TBL] [Abstract][Full Text] [Related]
9. The dermal-based borderline melanocytic tumor: a categorical approach.
Magro CM; Crowson AN; Mihm MC; Gupta K; Walker MJ; Solomon G
J Am Acad Dermatol; 2010 Mar; 62(3):469-79. PubMed ID: 20159313
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
11. Survival in sentinel lymph node-positive pediatric melanoma.
Roaten JB; Partrick DA; Bensard D; Pearlman N; Gonzalez R; Fitzpatrick J; McCarter MD
J Pediatr Surg; 2005 Jun; 40(6):988-92; discussion 992. PubMed ID: 15991183
[TBL] [Abstract][Full Text] [Related]
12. Melanoma in children and the use of sentinel lymph node biopsy.
Bütter A; Hui T; Chapdelaine J; Beaunoyer M; Flageole H; Bouchard S
J Pediatr Surg; 2005 May; 40(5):797-800. PubMed ID: 15937817
[TBL] [Abstract][Full Text] [Related]
13. Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas.
Busam KJ; Murali R; Pulitzer M; McCarthy SW; Thompson JF; Shaw HM; Brady MS; Coit DG; Dusza S; Wilmott J; Kayton M; Laquaglia M; Scolyer RA
Am J Surg Pathol; 2009 Sep; 33(9):1386-95. PubMed ID: 19609204
[TBL] [Abstract][Full Text] [Related]
14. Spitz nevus and atypical spitzoid neoplasm.
Miteva M; Lazova R
Semin Cutan Med Surg; 2010 Sep; 29(3):165-73. PubMed ID: 21051010
[TBL] [Abstract][Full Text] [Related]
15. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
16. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
17. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
18. The prognostic importance of sentinel lymph node biopsy in thin melanoma.
Ranieri JM; Wagner JD; Wenck S; Johnson CS; Coleman JJ
Ann Surg Oncol; 2006 Jul; 13(7):927-32. PubMed ID: 16788753
[TBL] [Abstract][Full Text] [Related]
19. Utility of lymph node assessment for atypical spitzoid melanocytic neoplasms.
Ghazi B; Carlson GW; Murray DR; Gow KW; Page A; Durham M; Kooby DA; Parker D; Rapkin L; Lawson DH; Delman KA
Ann Surg Oncol; 2010 Sep; 17(9):2471-5. PubMed ID: 20224858
[TBL] [Abstract][Full Text] [Related]
20. Our experience of melanoma thickness as a predictor of outcome of sentinel node biopsy.
Homolak D; Vucetić B; Puljiz Z; Blajć I; Vurnek Zivković M; Situm M
Coll Antropol; 2008 Oct; 32 Suppl 2():57-60. PubMed ID: 19138008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]